Why Am I Not Losing Weight on Victoza?

Victoza is approved for type 2 diabetes, not weight loss, and its maximum dose is nearly half what’s used in the dedicated weight loss version of the same drug. That single fact explains why many people on Victoza see little or no change on the scale. But dose isn’t the only factor. Your body’s metabolic response, other medications, eating patterns, and how long you’ve been on the drug all play a role.

Victoza’s Dose Is Too Low for Significant Weight Loss

Victoza and Saxenda contain the exact same active ingredient: liraglutide. The difference is the dose. Victoza maxes out at 1.8 mg per day, prescribed to manage blood sugar. Saxenda, the version approved specifically for weight management, goes up to 3.0 mg per day. That’s nearly 70% more medication. Saxenda’s prescribing guidelines are explicit: weight loss efficacy has not been established at lower doses like 1.2 or 1.8 mg, which are the doses you’d be taking on Victoza.

So if your doctor prescribed Victoza for diabetes and you were hoping for meaningful weight loss as a bonus, the math is working against you from the start. Some people do lose a few pounds on Victoza because liraglutide suppresses appetite at any dose, but the effect is modest compared to what the higher Saxenda dose delivers.

How Liraglutide Affects Weight

Liraglutide works on GLP-1 receptors throughout your body. In the pancreas, it helps release insulin in response to meals. In the brain, it targets areas that regulate appetite, reducing hunger signals and making you feel full sooner. It also slows gastric emptying, meaning food sits in your stomach longer after a meal, which contributes to that “I’m done eating” feeling. Additionally, liraglutide increases levels of leptin, a hormone that signals your brain to stop eating.

All of these effects are dose-dependent. At 1.8 mg, they’re enough to improve blood sugar control and may take the edge off your appetite. At 3.0 mg, the appetite suppression becomes strong enough to produce clinically meaningful weight loss. If you’re on Victoza and not feeling much difference in your hunger levels, the dose is the most likely explanation.

Your Body Adapts to Burn Fewer Calories

Even when liraglutide does produce weight loss, your body fights back through a process called metabolic adaptation. As you lose weight, your total energy expenditure drops by more than the lost body mass alone would predict. Your body becomes more efficient, burning fewer calories for the same activities.

Research published in Cell Reports Medicine found that GLP-1 medications reduce the calories you burn through physical activity and everyday movement (walking, fidgeting, even just standing) by roughly 170 calories per day, even when weight loss is minimal. During a 10% loss of body weight, the energy you spend on all non-resting activity can drop by about 20%, which translates to around 200 fewer calories burned per day. This reduction in movement-related energy expenditure accounts for 50% to 70% of the total decrease in daily calorie burn after weight loss.

The practical consequence: the calorie deficit that produced your initial results gradually shrinks until weight loss stalls. This plateau is a normal biological response, not a sign the medication has stopped working. But on a lower Victoza dose, the margin was already thin, so the plateau can hit earlier and feel more frustrating.

Loss of lean muscle mass compounds the problem. Muscle is metabolically active tissue, and GLP-1 medications can reduce both fat and muscle. Less muscle means a lower resting metabolic rate, making it even harder to maintain a calorie deficit over time.

Other Medications May Be Working Against You

Several common medications promote weight gain or make losing weight harder. If you’re taking any of the following alongside Victoza, the effects may cancel each other out:

  • Insulin: Particularly higher doses. Insulin is a storage hormone, and excess circulating insulin promotes fat storage. Many people with type 2 diabetes are on both Victoza and insulin.
  • Beta-blockers: Prescribed for high blood pressure and heart conditions, these medications lower your resting metabolic rate and can reduce exercise tolerance, making it harder to burn calories.
  • Corticosteroids: Used for inflammation and autoimmune conditions, these increase appetite and promote fat accumulation, especially around the midsection.
  • Certain antidepressants and antipsychotics: Many psychiatric medications are associated with significant weight gain through changes in appetite regulation and metabolism.
  • Sulfonylureas: Another class of diabetes medication that can cause weight gain by stimulating insulin release regardless of blood sugar levels.

If you’re taking multiple medications that promote weight gain, Victoza’s modest appetite-suppressing effects at diabetes doses simply may not be strong enough to overcome them.

Calorie Intake Still Matters

Liraglutide reduces appetite, but it doesn’t eliminate it. Some people find that the appetite suppression on Victoza is subtle enough that they eat the same amount as before, especially if they eat on a schedule rather than in response to hunger, or if they eat calorie-dense foods that don’t trigger strong fullness signals.

Liquid calories are a common blind spot. Sugary drinks, alcohol, and even fruit juices bypass many of the satiety signals that liraglutide enhances. Because the medication works partly by slowing gastric emptying, liquids that move through the stomach quickly won’t produce the same “full” feeling that solid food does.

Eating speed also plays a role. Liraglutide’s satiety signals take time to kick in. If you eat quickly, you can overshoot your body’s fullness cues before the medication has a chance to work. Slowing down at meals gives the delayed gastric emptying a chance to signal that you’ve had enough.

The Titration Phase Won’t Produce Results

Victoza starts at 0.6 mg per day for the first week, a dose that exists solely to reduce nausea and digestive side effects. It has no meaningful effect on blood sugar or appetite. After one week, the dose increases to 1.2 mg, and after at least another week, it can increase to the maximum of 1.8 mg. If you’re still in the first few weeks of treatment and wondering why the scale hasn’t moved, you may not yet be on a dose high enough to produce any appetite suppression at all.

Even at the full 1.8 mg dose, give it at least 8 to 12 weeks before evaluating results. The appetite and metabolic effects build gradually, and early weight fluctuations from water retention or digestive changes can mask fat loss.

What You Can Realistically Expect

On Victoza at diabetes doses, most people lose a modest amount of weight or maintain their current weight more easily than they would without the medication. Losing 5% or more of your body weight on 1.8 mg is possible but not guaranteed, and it typically requires attention to diet and activity alongside the medication.

If weight loss is a primary goal and you have a BMI that qualifies, your doctor may consider switching you to Saxenda (the same drug at a higher dose) or a different GLP-1 medication approved for weight management. The higher doses provide substantially stronger appetite suppression, and the clinical evidence behind them is built around weight loss as the primary outcome rather than blood sugar control.

Resistance training can help counteract the metabolic adaptation that stalls weight loss. By preserving or building lean muscle, you maintain a higher resting metabolic rate and offset the drop in daily energy expenditure that the medication and weight loss itself cause. Even two to three sessions per week of strength-focused exercise can make a measurable difference in how many calories your body burns at rest.